Belzer A - Search Results

1

A preliminary single-site evaluation of the impact of the curriculum for advancing racial equity (CARE) initiative on resident education.

Swallow MA, Belzer A, Leventhal J, Ramachandran S. Swallow MA, et al. Among authors: belzer a. Arch Dermatol Res. 2024 Dec 21;317(1):149. doi: 10.1007/s00403-024-03663-0. Arch Dermatol Res. 2024. PMID: 39708088 No abstract available.

2

Picosecond neodymium-doped yttrium-aluminum-garnet laser therapy for pigmentation due to lichen planus pigmentosus in a patient with skin of color.

Belzer A, Swallow MA, Gowen M, Suozzi KC. Belzer A, et al. JAAD Case Rep. 2023 Feb 13;34:45-47. doi: 10.1016/j.jdcr.2023.01.029. eCollection 2023 Apr. JAAD Case Rep. 2023. PMID: 36936863 Free PMC article. No abstract available.

3

The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the Literature.

Belzer A, Pach JJ, Valido K, Leventhal JS. Belzer A, et al. Am J Clin Dermatol. 2024 May;25(3):435-445. doi: 10.1007/s40257-024-00847-2. Epub 2024 Feb 16. Am J Clin Dermatol. 2024. PMID: 38366030 Review.

4

The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy.

Belzer A, Mortlock RD, Pach J, Cohen JM, Leventhal JS. Belzer A, et al. J Am Acad Dermatol. 2023 May;88(5):1198-1200. doi: 10.1016/j.jaad.2023.01.002. Epub 2023 Jan 9. J Am Acad Dermatol. 2023. PMID: 36634749 Free PMC article. No abstract available.

5

The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases.

Pach J, Valido K, Belzer A, Leventhal JS. Pach J, et al. Among authors: belzer a. Am J Clin Dermatol. 2024 Jul;25(4):595-607. doi: 10.1007/s40257-024-00866-z. Epub 2024 May 20. Am J Clin Dermatol. 2024. PMID: 38767827 Review.

6

Spectrum of Dermatologic Adverse Events Associated With Amivantamab Use.

Belzer A, Nguyen MO, Talsania A, Haldas J, Smith J, Leventhal JS. Belzer A, et al. JAMA Dermatol. 2023 Jan 1;159(1):109-111. doi: 10.1001/jamadermatol.2022.4466. JAMA Dermatol. 2023. PMID: 36416832 Free PMC article.

7

The spectrum of cutaneous immune-related adverse events in patients with skin of color.

Belzer A, Mortlock RD, Olamiju B, Olino K, Cohen JM, Leventhal JS. Belzer A, et al. J Am Acad Dermatol. 2023 May;88(5):1156-1158. doi: 10.1016/j.jaad.2022.11.051. Epub 2022 Dec 5. J Am Acad Dermatol. 2023. PMID: 36470309 Free PMC article. No abstract available.

8

Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability.

Belzer A, Pach J, Mortlock RD, Clune J, Olino K, Sznol M, Bhatia A, Burtness B, Christensen S, Leventhal JS. Belzer A, et al. JAAD Int. 2023 Feb 26;11:174-175. doi: 10.1016/j.jdin.2023.02.007. eCollection 2023 Jun. JAAD Int. 2023. PMID: 37252181 Free PMC article. No abstract available.

9

The association of cutaneous squamous cell carcinoma and basal cell carcinoma with solid organ transplantation: a cross-sectional study of the All Of Us Research Program.

Belzer A, Leasure AC, Cohen JM, Perkins SH. Belzer A, et al. Int J Dermatol. 2023 Oct;62(10):e564-e566. doi: 10.1111/ijd.16700. Epub 2023 May 5. Int J Dermatol. 2023. PMID: 37144784 No abstract available.

10

The association of anxiety with granuloma annulare: a case-control study of the National Institutes of Health 'All of Us' research programme.

Belzer A, Leasure AC, Damsky W, Cohen JM. Belzer A, et al. Br J Dermatol. 2023 Mar 30;188(4):558-560. doi: 10.1093/bjd/ljac114. Br J Dermatol. 2023. PMID: 36715356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters